What is a Patient Information Leaflet and why is it useful?
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PLGB 20011/0063.
Feraccru 30mg hard capsules
Package leaflet: Information for the patient
Feraccru 30 mg hard capsules iron
(as ferric maltol)
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it onto others. It may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Feraccru is and what it is used for.
2. What you need to know before you take Feraccru.
3. How to take Feraccru.
4. Possible side effects.
5. How to store Feraccru.
6. Contents of the pack and other information.
1. What Feraccru is and what it is used for
Feraccru contains iron (as ferric maltol). Feraccru is used in adults to treat low iron stores in your body. Low iron causes anaemia (too few red blood cells).
2. What you need to know before you take Feraccru
Do not take Feraccru:
- If you are allergic to ferric maltol or any of the other ingredients of this medicine (listed in section 6).
- If you have any illness causing iron overload or a disturbance in how your body uses iron.
- If you have received multiple blood transfusions.
Warnings and precautions
Before starting treatment, your doctor will use a blood test to make sure that your anaemia is not severe or caused by anything other than iron deficiency (low iron stores).
You should avoid taking Feraccru if you are experiencing a “flare” of your inflammatory bowel disease (IBD).
You should not take Feraccru if you are taking dimercaprol (a medicine used to remove toxic metals from the blood), chloramphenicol (used to treat bacterial infections), or methyldopa (used to treat high blood pressure).
Children and adolescents
Do not give this treatment to children or adolescents 17 years and under as it has not been studied in this age group. Too much iron is dangerous in children, infants and toddlers and can be life-threatening.
Other medicines and Feraccru
Tell your doctor or pharmacist if you are taking any other medicines.
You should leave at least 2 hours between taking Feraccru and taking:
- Supplements or medicines that contain magnesium or calcium.
Some antibiotics, such as ciprofloxacin tetracycline, levofloxacin, moxifloxacin, norfloxacin and ofloxacin.
- Bisphosphonates (used to treat bone diseases).
- Penicillamine (used to bind metals).
- Some medicines used to treat Parkinson’s disease (entacapone, levodopa) and thyroid problems (levothyroxine).
- Mycophenolate (used with other medicines to prevent the body rejecting transplanted organs).
You should not be given iron by injection or infusion (intravenously) while you are taking Feraccru.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Feraccru is unlikely to have any effect on the ability to drive and use machines.
Feraccru contain lactose,
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Feraccru contains Sunset Yellow FCF (E 110) and Allura Red AC (E 129).
Sunset Yellow FCF (E110) and Allura Red AC (E129) may cause allergic reactions.
Feraccru contains sodium
This medicine contains less than 1 mmol sodium (23 mg) per capsule, that is to say essentially ‘sodium-free’.
3. How to take Feraccru
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one capsule (30 mg) taken twice a day, morning and evening.
Take this medicine on an empty stomach with half a glass of water (one hour before a meal, or at least 2 hours after a meal).
Swallow the capsules whole.
If you take more Feraccru than you should
Taking too much Feraccru can make the person feel sick or be sick and cause bellyache and diarrhoea. Call your doctor or hospital straightaway if you or another person has taken too much Feraccru. Make sure that you take this leaflet and any remaining capsules with you to show to the doctor.
If you forget to take your Feraccru
Skip the missed dose and take the next dose as normal. Do not take a double dose to make up for a forgotten capsule.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most common side effects (may affect up to 1 in 10 people) of Feraccru are:
- Stomach pain
- Flatulence (wind)
- Discomfort or bloating in the stomach
- Nausea (feeling sick)
- Discoloured faeces
Uncommon side effects (may affect up to 1 in 100 people) are:
- Stiff joints,
- Pain in fingers/toes,
- Skin redness,
- Abdominal bloating, abdominal pain, nausea and diarrhoea due to increase in bacteria in the gut
- Blood tests may show increased levels of proteins (alkaline phosphatase, Gamma-glutamyltransferase) that break down chemicals in the blood and of a hormone (Thyroid stimulating hormone) that stimulates the thyroid gland.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:
United Kingdom -
or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Feraccru
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP: The expiry date refers to the last day of that month.
Do not use this medicine for more than 45 days after first opening the bottle.
Store below 25°C.
6. Contents of the pack and other information
What Feraccru contains
The active substance is 30 mg of iron as ferric maltol.
The other ingredients are:
- Lactose monohydrate (see section 2)
- Sodium laurilsulfate
- Magnesium stearate
- Colloidal anhydrous silica
- Crospovidone (Type A)
- Brilliant Blue FCF (E133)
- Allura Red AC (E129) (see section 2)
- Titanium dioxide (E171)
- Sunset Yellow FCF (E110) (see section 2)
- Shellac glaze-45% (20 % esterfied) in Ethanol
- Iron oxide black
- Propylene glycol
- Ammonium hydroxide
What Feraccru looks like and contents of the pack
Feraccru is a red hard capsule printed “30” containing a reddish-brown powder. Feraccru is available in bottles, each containing 56 capsules.
Marketing Authorisation Holder
40 boulevard de champaret
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
This leaflet was last revised in June 2021
Other sources of information
If you need the information on this leaflet in an alternative format, such as large text, please ring Medical Information on 01895 826 606